Dan-yang Tang and Wei-jiang Zhao Pages 51 - 64 ( 14 )
Spinal cord injury (SCI) is a long-lasting damage in the spinal cord that leads to paraparesis, paraplegia, quadriplegia and other lifetime disabilities. The underlying mechanisms responsible for the failure of axonal regeneration after SCI remain only partially understood. Although a spectrum of medical treatments has been made available for this disease, the therapeutic effects remain disappointing. The emergence of antibody treatment has paved a new pathway for the management of SCI. In this current review, we summarized the application of antibodies in SCI in studies of myelin repair, neuroprotection, axon outgrowth, and anti-immune reaction. In the meantime, the combination treatment of the antibody with other reagents or stem cell transplant was also reviewed.
Antibody, spinal cord injury, neuroprotective, myelin repair, anti-immune reaction, neuropathic pain
Center for Neuroscience, Shantou University Medical College, 22 Xin Ling Rd, Jinping District, Shantou, Guangdong 515041, People’s Republic of